-
Researchers develop tool to predict how patients will respond to common multiple sclerosis drug
26 Sep 2025 02:47 GMT
… most commonly used drugs for treating multiple sclerosis.
Despite its effectiveness … poor outcomes with natalizumab treatment are associated with … the influence of the drug. The cells become … for other diseases and treatments," says Helder Nakaya …
-
San Francisco firm's AI-powered sleeve aims to revolutionize treatment for cerebral palsy, multiple sclerosis
25 Sep 2025 17:32 GMT
-
<![CDATA[Latest Updates and Future Directions in Multiple Sclerosis Care: Kathleen Costello, CRNP, MSCN]]>
25 Sep 2025 16:52 GMT
… as we develop better treatments, better care options for … so that the right drug is given to the … European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, … News Release. Consortium of Multiple Sclerosis Centers. Published April 17 …
-
Gianelli & Morris Files Lawsuit Against Anthem Blue Cross Alleging Wrongful Denial of Medically Necessary MS Treatment
25 Sep 2025 15:00 GMT
… deemed medically necessary to treat multiple sclerosis.
LOS ANGELES, CA, UNITED … cover medically necessary treatment for Callie, who suffers from multiple sclerosis.
According to … HSCT) as the most effective treatment for her progressive and debilitating …
-
Group creates tool to predict whether multiple sclerosis medication will be effective for patients
25 Sep 2025 14:48 GMT
… most commonly used drugs for treating multiple sclerosis.
Despite its effectiveness … poor outcomes with natalizumab treatment are associated with distinct … the influence of the drug. The cells become … for other diseases and treatments,” says Helder Nakaya, …
-
Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients
25 Sep 2025 12:00 GMT
… U.S. Food and Drug Administration, FDA aligned … lateral sclerosis (ALS) and multiple sclerosis (MS), today announced … European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), … Parkinson’s disease, and multiple sclerosis. CNM-Au8® is an …
-
Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
25 Sep 2025 10:46 GMT
… , Reinforcing the Drug's … multiple sclerosis (PPMS) and non-active secondary progressive multiple sclerosis … for the treatment of relapsing multiple sclerosis, for … relapsing-remitting multiple sclerosis and progressive multiple sclerosis. Vidofludimus …
-
New Study Reveals Menopause Influences Multiple Sclerosis Symptoms and Associated Health Conditions
25 Sep 2025 01:55 GMT
… for Treatment and Research in Multiple Sclerosis (ECTRIMS … women diagnosed with multiple sclerosis (MS). This … therapeutic approaches.
Multiple sclerosis, a chronic … Barcelona, Spain.
Keywords:
Multiple sclerosis, autoimmune disorders, neuroimmunology, …
-
Menopause Found to shape initial symptoms and comorbidities in multiple sclerosis
25 Sep 2025 01:18 GMT
… the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) reveals … menopause may significantly influence how multiple sclerosis (MS) first presents in … for more targeted, personalised treatment strategies for women tailored to …
-
Consumption of ultra-processed foods may exacerbate disease activity in early multiple sclerosis
25 Sep 2025 01:18 GMT
… exacerbate disease activity in early multiple sclerosis (MS), according to new … the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025).
Researchers … after adjustment for age, sex, treatment allocation, baseline disease burden, …
About
© 1995-2025